Computer Motion Exceeds Guidance; Outlook Positive; Fourth Quarter Revenue Up 95% Sequentially.

Business Editors & Health/Medical Writers

SANTA BARBARA, Calif.--(BUSINESS WIRE)--Jan. 22, 2003

Computer Motion, Inc. (Nasdaq:RBOT), the world's leading developer of surgical robotic systems serving over 900 customers and 3,000 surgeons in 32 countries, today announced record revenue results for the fourth quarter ended December 31, 2002. The company recorded approximately $8,800,000 in revenue, exceeding previous written guidance and up 95%, when compared to the third quarter of 2002, and 2% year over year. The improved results were driven by increased sales across all product lines, and expanding surgeon interest in the fields of pediatric, bariatric, cardiac, and general surgery.

Bob Duggan, Chairman and CEO of Computer Motion, commented, "2002 concluded with a strong quarter. By successfully executing our plans, it appears we have re-established momentum across all product lines and improved market share in robotic surgical systems." Mr. Duggan continued, "In 2003, we believe that we will continue to leverage our strengthened executive management team, forward our core platform technology, improve our competitive position, and drive revenue at a faster rate than our recurring operating expenses."

"This has been a good quarter for Computer Motion. We delivered revenues above our written guidance while completing our sales and marketing transition. I expect our new organization to continually improve upon this performance throughout 2003," added Joseph DeVivo, President and Chief Operating Officer.

Computer Motion's products include: the ZEUS(R) Surgical System and accessories for minimally invasive surgery, the HERMES(R) Control Center, a centralized system that enables the surgeon to voice control a network of "smart" medical devices, and the AESOP(R) Robotic Endoscope Positioner, which was also the first surgical robot to be made commercially available in the U.S. The company's newest product, the SOCRATES(TM) Telecollaboration System, is the first device in the newly created FDA category of Robotic Telemedicine Devices, and is designed to facilitate surgeon collaboration using video and audio conferencing, shared control of the endoscopic camera, and video annotation on the surgical image in the operating room. The company's products are CE-Marked for commercial sale in the European Community. The company's Web site is www.ComputerMotion.com.

This press release contains forward-looking statements concerning the company's business and products. Actual results may differ materially depending on a number of risk factors, including the risks of competition and competing technologies, duration or suspension of clinical studies, regulatory clearances and approvals, and physician, hospital and payor acceptance of the company's products. These factors and other risks inherent in the company's business are described from time to time in the company's Securities and Exchange Commission filings, including its Annual Report on Form 10-K. The company undertakes no obligation to revise the forward-looking statements contained herein to reflect events or circumstances after the date hereof to reflect the occurrence of unanticipated events.

RBOT-Santa Barbara